Clinical trial
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients…
NCT00457002 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00457002 |
|---|---|
| Title | Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness |
| Official title | A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization. |
| Acronym | ADOPT |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Venous Thrombosis, Pulmonary Embolism |
| Intervention type | Drug |
| Interventions | Apixaban, Enoxaparin |
| Enrollment | 6,758 |
| Start date | Jun 1, 2007 |
| Primary completion | May 1, 2011 |
| Completion | May 1, 2011 |
| First posted | Apr 5, 2007 |
| Last update posted | Dec 8, 2015 |
| Countries | Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czechia, Denmark, France, Germany and 23 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: